Next Article in Journal
Preparative Biocatalytic Synthesis of α-Ketoglutaramate
Previous Article in Journal
Structural Determination and Genetic Identification of the O-Antigen from an Escherichia coli Strain, LL004, Representing a Novel Serogroup
Previous Article in Special Issue
Assessment of the Effects of Dietary Vitamin D Levels on Olanzapine-Induced Metabolic Side Effects: Focus on the Endocannabinoidome-Gut Microbiome Axis
Review

Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update

1
Departamento de Farmacología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico
2
Departamento de Biología de la Reproducción Dr. Carlos Gual Castro, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Vasco de Quiroga No. 15, Belisario Domínguez Sección XVI, Tlalpan, Ciudad de México 14080, Mexico
3
Departamento de Biología Molecular y Biotecnología, Instituto de Investigaciones Biomédicas, Universidad Nacional Autónoma de México, Ciudad de México 04510, Mexico
*
Authors to whom correspondence should be addressed.
Academic Editors: Francesca Silvagno and Loredana Bergandi
Int. J. Mol. Sci. 2021, 22(23), 12741; https://doi.org/10.3390/ijms222312741
Received: 20 October 2021 / Revised: 16 November 2021 / Accepted: 19 November 2021 / Published: 25 November 2021
(This article belongs to the Special Issue The Role of Vitamin D in Human Health and Diseases)
Preclinical, clinical, and epidemiological studies indicate that vitamin D3 (VD) deficiency is a risk factor for the development of breast cancer. Underlying mechanisms include the ability of calcitriol to induce cell differentiation, inhibit oncogenes expression, and modify different signaling pathways involved in the control of cell proliferation. In addition, calcitriol combined with different kinds of antineoplastic drugs has been demonstrated to enhance their beneficial effects in an additive or synergistic fashion. However, a recognized adjuvant regimen based on calcitriol for treating patients with breast cancer has not yet been fully established. Accordingly, in the present work, we review and discuss the preclinical and clinical studies about the combination of calcitriol with different oncological drugs, aiming to emphasize its main therapeutic benefits and opportunities for the treatment of this pathology. View Full-Text
Keywords: breast cancer; calcitriol; drug combination; efficacy breast cancer; calcitriol; drug combination; efficacy
Show Figures

Graphical abstract

MDPI and ACS Style

Segovia-Mendoza, M.; García-Quiroz, J.; Díaz, L.; García-Becerra, R. Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update. Int. J. Mol. Sci. 2021, 22, 12741. https://doi.org/10.3390/ijms222312741

AMA Style

Segovia-Mendoza M, García-Quiroz J, Díaz L, García-Becerra R. Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update. International Journal of Molecular Sciences. 2021; 22(23):12741. https://doi.org/10.3390/ijms222312741

Chicago/Turabian Style

Segovia-Mendoza, Mariana, Janice García-Quiroz, Lorenza Díaz, and Rocío García-Becerra. 2021. "Combinations of Calcitriol with Anticancer Treatments for Breast Cancer: An Update" International Journal of Molecular Sciences 22, no. 23: 12741. https://doi.org/10.3390/ijms222312741

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop